Delivery Order SPE2DB22D3004-SPE2DB25FQA39
Award Date
3/25/25
Potential Completion Date
3/26/25
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,329.56, is for the delivery of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a medical product used for healthcare purposes. The contract has an ultimate completion date of February 26, 2025 and is a firm fixed-price delivery order contract. The contract was not set aside for any specific...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,266.50, is for the delivery of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a pharmaceutical product, to support federal healthcare programs. The contract is a firm fixed-price delivery order with a completion date of January 28, 2025. It is not designated as a set-aside contract. Amerisourcebergen...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,585.83, is for the delivery of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a pharmaceutical product, to support military healthcare programs. The contract is a Firm Fixed Price type and has an ultimate completion date of March 3, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a $5,022.12 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML medical products. This contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,629.46, is for the delivery of Liraglutide 3-pak 18 mg/3 ml 3 ml, a diabetes medication. The contract has a firm fixed price and an ultimate completion date of July 18, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,343.68 fixed-price delivery order is for the supply of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a pharmaceutical product, with a period of performance through April 15, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,316.76, is a delivery order for the procurement of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a medical product. The contract has an ultimate completion date of April 1, 2025 and was awarded on March 31, 2025. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,007.13, is for the delivery of Liraglutide 3-Pak 18 mg/3 ml 3 ml, a medication used for the treatment of diabetes. The contract is a firm fixed-price delivery order with a completion date of March 28, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $2,589.67, is for the delivery of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a specialty medication used to treat diabetes. The contract has an ultimate completion date of March 17, 2025 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,397.78, is a Firm Fixed Price Delivery Order for the supply of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML. The contract has an ultimate completion date of April 10, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...